HEADER HYDROLASE 30-MAR-10 3MDQ TITLE CRYSTAL STRUCTURE OF AN EXOPOLYPHOSPHATASE (CHU_0316) FROM CYTOPHAGA TITLE 2 HUTCHINSONII ATCC 33406 AT 1.50 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXOPOLYPHOSPHATASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.6.1.11; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CYTOPHAGA HUTCHINSONII; SOURCE 3 ORGANISM_TAXID: 269798; SOURCE 4 STRAIN: ATCC 33406 / NCIMB 9469; SOURCE 5 GENE: PPX, CHU_0316; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS EXOPOLYPHOSPHATASE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 01-FEB-23 3MDQ 1 REMARK SEQADV REVDAT 4 17-JUL-19 3MDQ 1 REMARK LINK REVDAT 3 08-NOV-17 3MDQ 1 REMARK REVDAT 2 13-JUL-11 3MDQ 1 VERSN REVDAT 1 12-MAY-10 3MDQ 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF AN EXOPOLYPHOSPHATASE (CHU_0316) FROM JRNL TITL 2 CYTOPHAGA HUTCHINSONII ATCC 33406 AT 1.50 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 56672 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.153 REMARK 3 FREE R VALUE : 0.178 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2875 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3862 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.2530 REMARK 3 BIN FREE R VALUE SET COUNT : 219 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2408 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 350 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 16.01 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.38000 REMARK 3 B22 (A**2) : 0.29000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.064 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.065 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.041 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.473 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.965 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2740 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1796 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3737 ; 1.560 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4420 ; 0.957 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 362 ; 5.455 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 119 ;36.537 ;24.370 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 494 ;12.440 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.650 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 436 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3123 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 534 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1715 ; 1.664 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 699 ; 0.436 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2807 ; 2.812 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1025 ; 4.546 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 930 ; 7.057 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 314 REMARK 3 ORIGIN FOR THE GROUP (A): 35.3504 4.7463 69.2282 REMARK 3 T TENSOR REMARK 3 T11: 0.0021 T22: 0.0027 REMARK 3 T33: 0.0061 T12: 0.0012 REMARK 3 T13: 0.0009 T23: -0.0006 REMARK 3 L TENSOR REMARK 3 L11: 0.2309 L22: 0.3265 REMARK 3 L33: 0.4532 L12: 0.0980 REMARK 3 L13: 0.0350 L23: 0.1080 REMARK 3 S TENSOR REMARK 3 S11: 0.0023 S12: -0.0091 S13: 0.0112 REMARK 3 S21: -0.0038 S22: 0.0018 S23: 0.0093 REMARK 3 S31: -0.0198 S32: 0.0033 S33: -0.0042 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: (1) HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. (2) ATOM RECORDS CONTAIN RESIDUAL B FACTORS REMARK 3 ONLY. (3) A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REMARK 3 REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. (4) CHLORIDE (CL) AND SULFATE (SO4) IONS REMARK 3 FROM CRYSTALLIZATION CONDITION, AND GLYCEROL (GOL) MOLECULES REMARK 3 FROM EITHER CRYSTALLIZATION OR CRYO CONDITION ARE MODELED. REMARK 4 REMARK 4 3MDQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000058418. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96109,0.97934,0.97925 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT COLLIMATING MIRROR, TOROID REMARK 200 FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56714 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.786 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4500M AMMONIUM SULFATE, 13.6000% REMARK 280 GLYCEROL, NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.34350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.68700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.66750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.68700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.34350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.66750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 SER A 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 24 CG OD1 ND2 REMARK 470 ASP A 25 CG OD1 OD2 REMARK 470 ARG A 26 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 74 CG1 CG2 REMARK 470 ARG A 202 NE CZ NH1 NH2 REMARK 470 ARG A 225 CD NE CZ NH1 NH2 REMARK 470 LYS A 227 CG CD CE NZ REMARK 470 GLU A 231 CD OE1 OE2 REMARK 470 LYS A 232 CE NZ REMARK 470 LYS A 284 CD CE NZ REMARK 470 SER A 287 OG REMARK 470 LYS A 311 CD CE NZ REMARK 470 SER A 314 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 109 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 81 -135.78 -119.54 REMARK 500 GLU A 128 -139.58 53.83 REMARK 500 ASN A 150 26.31 -144.61 REMARK 500 SER A 210 -169.66 83.76 REMARK 500 SER A 287 60.68 -109.52 REMARK 500 THR A 288 150.32 164.05 REMARK 500 SER A 297 -145.38 -146.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 315 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 316 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 317 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 318 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 319 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 320 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 321 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 322 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 323 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 397998 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3MDQ A 1 314 UNP Q11YA9 Q11YA9_CYTH3 1 314 SEQADV 3MDQ GLY A 0 UNP Q11YA9 EXPRESSION TAG SEQRES 1 A 315 GLY MSE SER GLN ARG ILE GLY VAL ILE ASP MSE GLY THR SEQRES 2 A 315 ASN THR PHE HIS LEU LEU ILE THR ASP ILE VAL ASN ASP SEQRES 3 A 315 ARG PRO HIS THR LEU VAL ASN GLU LYS SER ALA VAL GLY SEQRES 4 A 315 LEU GLY LYS GLY GLY ILE THR LYS GLY PHE ILE THR GLU SEQRES 5 A 315 GLU ALA MSE ASP ARG ALA LEU ASP THR LEU LYS LYS PHE SEQRES 6 A 315 ARG VAL ILE LEU ASP GLU HIS ALA VAL VAL HIS VAL ILE SEQRES 7 A 315 ALA THR GLY THR SER ALA VAL ARG SER GLY SER ASN LYS SEQRES 8 A 315 GLN VAL LEU ILE ASP ARG ILE LYS LYS GLU VAL ASN ILE SEQRES 9 A 315 ASP VAL GLU VAL ILE ASP GLY ALA ARG GLU ALA GLU LEU SEQRES 10 A 315 ILE PHE ARG GLY VAL GLN GLN ALA VAL PRO MSE GLU ASP SEQRES 11 A 315 HIS ILE SER LEU ALA MSE ASP ILE GLY GLY GLY SER VAL SEQRES 12 A 315 GLU PHE ILE ILE GLY ASN LYS ASN GLU ILE LEU TRP LYS SEQRES 13 A 315 GLN SER PHE GLU ILE GLY GLY GLN ARG LEU ILE ASP ARG SEQRES 14 A 315 PHE HIS VAL HIS ASP PRO MSE ARG GLU ASP ASP ARG VAL SEQRES 15 A 315 MSE MSE HIS ASN TYR PHE ASP GLU VAL LEU VAL PRO LEU SEQRES 16 A 315 GLU LYS ALA ILE ASN THR TRP ARG PRO THR GLN LEU ILE SEQRES 17 A 315 GLY CYS SER GLY THR PHE ASP THR LEU ALA GLU MSE ASN SEQRES 18 A 315 ILE GLN HIS HIS ARG GLU LYS ILE ALA LEU GLU LYS GLN SEQRES 19 A 315 THR SER TYR LEU LEU SER LEU PRO ASP PHE ASN ARG LEU SEQRES 20 A 315 ARG LYS GLN LEU VAL ALA SER THR ARG ARG GLU ARG LEU SEQRES 21 A 315 ALA ILE ALA GLY MSE ILE GLU LEU ARG ALA ASP MSE VAL SEQRES 22 A 315 VAL VAL ALA ILE CYS LEU ILE GLU HIS VAL LEU LYS LEU SEQRES 23 A 315 VAL SER THR ASN ALA ILE THR VAL SER THR TYR SER LEU SEQRES 24 A 315 LYS GLU GLY VAL LEU TYR THR MSE LEU ASP GLY VAL LYS SEQRES 25 A 315 VAL GLY SER MODRES 3MDQ MSE A 10 MET SELENOMETHIONINE MODRES 3MDQ MSE A 54 MET SELENOMETHIONINE MODRES 3MDQ MSE A 127 MET SELENOMETHIONINE MODRES 3MDQ MSE A 135 MET SELENOMETHIONINE MODRES 3MDQ MSE A 175 MET SELENOMETHIONINE MODRES 3MDQ MSE A 182 MET SELENOMETHIONINE MODRES 3MDQ MSE A 183 MET SELENOMETHIONINE MODRES 3MDQ MSE A 219 MET SELENOMETHIONINE MODRES 3MDQ MSE A 264 MET SELENOMETHIONINE MODRES 3MDQ MSE A 271 MET SELENOMETHIONINE MODRES 3MDQ MSE A 306 MET SELENOMETHIONINE HET MSE A 10 8 HET MSE A 54 8 HET MSE A 127 8 HET MSE A 135 8 HET MSE A 175 16 HET MSE A 182 8 HET MSE A 183 16 HET MSE A 219 8 HET MSE A 264 8 HET MSE A 271 24 HET MSE A 306 8 HET CL A 315 1 HET CL A 316 1 HET SO4 A 317 5 HET SO4 A 318 5 HET SO4 A 319 5 HET SO4 A 320 5 HET GOL A 321 6 HET GOL A 322 6 HET GOL A 323 6 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 11(C5 H11 N O2 SE) FORMUL 2 CL 2(CL 1-) FORMUL 4 SO4 4(O4 S 2-) FORMUL 8 GOL 3(C3 H8 O3) FORMUL 11 HOH *350(H2 O) HELIX 1 1 GLY A 43 GLY A 47 5 5 HELIX 2 2 THR A 50 HIS A 71 1 22 HELIX 3 3 THR A 81 GLY A 87 1 7 HELIX 4 4 ASN A 89 ASN A 102 1 14 HELIX 5 5 ASP A 109 VAL A 125 1 17 HELIX 6 6 GLY A 161 PHE A 169 1 9 HELIX 7 7 ARG A 176 LEU A 191 1 16 HELIX 8 8 LEU A 191 ARG A 202 1 12 HELIX 9 9 SER A 210 ARG A 225 1 16 HELIX 10 10 ALA A 229 GLN A 233 5 5 HELIX 11 11 LEU A 240 SER A 253 1 14 HELIX 12 12 THR A 254 ALA A 260 1 7 HELIX 13 13 ILE A 265 VAL A 286 1 22 HELIX 14 14 SER A 297 GLY A 309 1 13 SHEET 1 A 5 ARG A 26 ALA A 36 0 SHEET 2 A 5 THR A 14 VAL A 23 -1 N PHE A 15 O SER A 35 SHEET 3 A 5 ARG A 4 MSE A 10 -1 N VAL A 7 O LEU A 18 SHEET 4 A 5 HIS A 75 GLY A 80 1 O HIS A 75 N GLY A 6 SHEET 5 A 5 VAL A 105 VAL A 107 1 O GLU A 106 N ALA A 78 SHEET 1 B 6 ILE A 152 PHE A 158 0 SHEET 2 B 6 VAL A 142 GLY A 147 -1 N ILE A 146 O TRP A 154 SHEET 3 B 6 SER A 132 ILE A 137 -1 N ALA A 134 O ILE A 145 SHEET 4 B 6 GLN A 205 CYS A 209 1 O ILE A 207 N LEU A 133 SHEET 5 B 6 ALA A 290 SER A 294 1 O SER A 294 N GLY A 208 SHEET 6 B 6 SER A 235 SER A 239 -1 N TYR A 236 O VAL A 293 LINK C ASP A 9 N MSE A 10 1555 1555 1.33 LINK C MSE A 10 N GLY A 11 1555 1555 1.31 LINK C ALA A 53 N MSE A 54 1555 1555 1.34 LINK C MSE A 54 N AASP A 55 1555 1555 1.34 LINK C MSE A 54 N BASP A 55 1555 1555 1.34 LINK C PRO A 126 N MSE A 127 1555 1555 1.32 LINK C MSE A 127 N GLU A 128 1555 1555 1.34 LINK C ALA A 134 N MSE A 135 1555 1555 1.34 LINK C MSE A 135 N ASP A 136 1555 1555 1.33 LINK C PRO A 174 N AMSE A 175 1555 1555 1.32 LINK C PRO A 174 N BMSE A 175 1555 1555 1.32 LINK C AMSE A 175 N ARG A 176 1555 1555 1.33 LINK C BMSE A 175 N ARG A 176 1555 1555 1.33 LINK C VAL A 181 N MSE A 182 1555 1555 1.33 LINK C MSE A 182 N AMSE A 183 1555 1555 1.33 LINK C MSE A 182 N BMSE A 183 1555 1555 1.33 LINK C AMSE A 183 N AHIS A 184 1555 1555 1.32 LINK C BMSE A 183 N BHIS A 184 1555 1555 1.33 LINK C AGLU A 218 N MSE A 219 1555 1555 1.34 LINK C BGLU A 218 N MSE A 219 1555 1555 1.33 LINK C MSE A 219 N ASN A 220 1555 1555 1.34 LINK C GLY A 263 N MSE A 264 1555 1555 1.33 LINK C MSE A 264 N ILE A 265 1555 1555 1.32 LINK C ASP A 270 N AMSE A 271 1555 1555 1.33 LINK C ASP A 270 N BMSE A 271 1555 1555 1.34 LINK C ASP A 270 N CMSE A 271 1555 1555 1.33 LINK C AMSE A 271 N VAL A 272 1555 1555 1.34 LINK C BMSE A 271 N VAL A 272 1555 1555 1.33 LINK C CMSE A 271 N VAL A 272 1555 1555 1.34 LINK C THR A 305 N MSE A 306 1555 1555 1.34 LINK C MSE A 306 N LEU A 307 1555 1555 1.32 CISPEP 1 ASP A 173 PRO A 174 0 5.69 SITE 1 AC1 3 GLY A 110 ALA A 111 HOH A 583 SITE 1 AC2 3 ARG A 164 ARG A 168 HOH A 568 SITE 1 AC3 10 THR A 12 THR A 81 GLY A 138 GLY A 139 SITE 2 AC3 10 GLY A 140 SER A 141 HOH A 375 HOH A 443 SITE 3 AC3 10 HOH A 633 HOH A 634 SITE 1 AC4 9 ASN A 13 THR A 14 GLY A 211 ARG A 268 SITE 2 AC4 9 MSE A 271 HOH A 413 HOH A 634 HOH A 635 SITE 3 AC4 9 HOH A 636 SITE 1 AC5 7 HIS A 16 LYS A 34 ASP A 214 ARG A 268 SITE 2 AC5 7 HOH A 530 HOH A 635 HOH A 654 SITE 1 AC6 6 HIS A 170 HIS A 172 ASP A 173 HOH A 406 SITE 2 AC6 6 HOH A 486 HOH A 558 SITE 1 AC7 9 THR A 50 GLU A 51 GLU A 52 GLU A 226 SITE 2 AC7 9 TYR A 236 LEU A 237 ASP A 242 HOH A 333 SITE 3 AC7 9 HOH A 643 SITE 1 AC8 9 LYS A 62 LYS A 99 GLU A 100 ARG A 180 SITE 2 AC8 9 VAL A 181 HIS A 184 ASN A 185 ASP A 188 SITE 3 AC8 9 HOH A 523 SITE 1 AC9 7 LEU A 18 THR A 20 THR A 29 TYR A 296 SITE 2 AC9 7 GLU A 300 TYR A 304 HOH A 653 CRYST1 44.687 89.335 89.374 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022378 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011194 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011189 0.00000